Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

December 01, 1999; Volume 56,Issue 6

Articles

  • You have access
    Differentiation of Substrate and Nonsubstrate Inhibitors of the High-Affinity, Sodium-Dependent Glutamate Transporters
    Hans P. Koch, Michael P. Kavanaugh, Christopher S. Esslinger, Noah Zerangue, John M. Humphrey, Susan G. Amara, A. Richard Chamberlin and Richard J. Bridges
    Molecular Pharmacology December 1999, 56 (6) 1095-1104; DOI: https://doi.org/10.1124/mol.56.6.1095
  • You have access
    Domain Interactions Affecting Human DNA Topoisomerase I Catalysis and Camptothecin Sensitivity
    Paola Fiorani, James F. Amatruda, Alessandra Silvestri, Richard H. Butler, Mary-Ann Bjornsti and Piero Benedetti
    Molecular Pharmacology December 1999, 56 (6) 1105-1115; DOI: https://doi.org/10.1124/mol.56.6.1105
  • You have access
    Dopamine D4/D2 Receptor Selectivity Is Determined by A Divergent Aromatic Microdomain Contained within the Second, Third, and Seventh Membrane-Spanning Segments
    Merrill M. Simpson, Juan A. Ballesteros, Victor Chiappa, Jiayun Chen, Makiko Suehiro, Deborah S. Hartman, Thierry Godel, Lenore A. Snyder, Thomas P. Sakmar and Jonathan A. Javitch
    Molecular Pharmacology December 1999, 56 (6) 1116-1126; DOI: https://doi.org/10.1124/mol.56.6.1116
  • You have access
    Analysis of Aryl Hydrocarbon Receptor-Mediated Signaling during Physiological Hypoxia Reveals Lack of Competition for the Aryl Hydrocarbon Nuclear Translocator Transcription Factor
    Richard S. Pollenz, Nikos A. Davarinos and Todd P. Shearer
    Molecular Pharmacology December 1999, 56 (6) 1127-1137; DOI: https://doi.org/10.1124/mol.56.6.1127
  • You have access
    Selective Potentiation of L-Type Calcium Channel Currents by Cocaine in Cardiac Myocytes
    Louis S. Premkumar
    Molecular Pharmacology December 1999, 56 (6) 1138-1142; DOI: https://doi.org/10.1124/mol.56.6.1138
  • You have access
    Platelet-Derived Growth Factor Inhibits α1D-Adrenergic Receptor Expression in Vascular Smooth Muscle Cells In Vitro and Ex Vivo
    Xiaohua Xin, Nengyu Yang and James E. Faber
    Molecular Pharmacology December 1999, 56 (6) 1143-1151; DOI: https://doi.org/10.1124/mol.56.6.1143
  • You have access
    Platelet-Derived Growth Factor-BB Inhibits Rat α1D-Adrenergic Receptor Gene Expression in Vascular Smooth Muscle Cells by Inducing AP-2-Like Protein Binding to α1D Proximal Promoter Region
    Xiaohua Xin, Nengyu Yang and James E. Faber
    Molecular Pharmacology December 1999, 56 (6) 1152-1161; DOI: https://doi.org/10.1124/mol.56.6.1152
  • You have access
    Adenosine Transporters in Bloodstream Forms of Trypanosoma brucei brucei: Substrate Recognition Motifs and Affinity for Trypanocidal Drugs
    Harry P. de Koning and Simon M. Jarvis
    Molecular Pharmacology December 1999, 56 (6) 1162-1170; DOI: https://doi.org/10.1124/mol.56.6.1162
  • You have access
    Molecular and Functional Characterization of Human P2X2 Receptors
    Kevin J. Lynch, Edward Touma, Wende Niforatos, Karen L. Kage, Edward C. Burgard, Tim van Biesen, Elizabeth A. Kowaluk and Michael F. Jarvis
    Molecular Pharmacology December 1999, 56 (6) 1171-1181; DOI: https://doi.org/10.1124/mol.56.6.1171
  • You have access
    Visualizing Differences in Ligand Regulation of Wild-Type and Constitutively Active Mutant β2-Adrenoceptor-Green Fluorescent Protein Fusion Proteins
    Alison J. McLean, Nicola Bevan, Stephen Rees and Graeme Milligan
    Molecular Pharmacology December 1999, 56 (6) 1182-1191; DOI: https://doi.org/10.1124/mol.56.6.1182
  • You have access
    Mibefradil Potently Blocks ATP-Activated K+ Channels in Adrenal Cells
    Juan Carlos Gomora, Judith A. Enyeart and John J. Enyeart
    Molecular Pharmacology December 1999, 56 (6) 1192-1197; DOI: https://doi.org/10.1124/mol.56.6.1192
  • You have access
    Regulation of Rat Hepatic Hydroxysteroid Sulfotransferase (SULT2-40/41) Gene Expression by Glucocorticoids: Evidence for a Dual Mechanism of Transcriptional Control
    Melissa Runge-Morris, Wei Wu and Thomas A. Kocarek
    Molecular Pharmacology December 1999, 56 (6) 1198-1206; DOI: https://doi.org/10.1124/mol.56.6.1198
  • You have access
    Putative Partial Agonist 1-Aminocyclopropanecarboxylic Acid Acts Concurrently as a Glycine-Site Agonist and a Glutamate-Site Antagonist at N-Methyl-d-aspartate Receptors
    Rinat Nahum-Levy, Linda H. Fossom, Phil Skolnick and Morris Benveniste
    Molecular Pharmacology December 1999, 56 (6) 1207-1218; DOI: https://doi.org/10.1124/mol.56.6.1207
  • You have access
    Effect of Multidrug Resistance-Reversing Agents on Transporting Activity of Human Canalicular Multispecific Organic Anion Transporter
    Zhe-Sheng Chen, Takeshi Kawabe, Mayumi Ono, Shunji Aoki, Tomoyuki Sumizawa, Tatsuhiko Furukawa, Takeshi Uchiumi, Morimasa Wada, Michihiko Kuwano and Shin-Ichi Akiyama
    Molecular Pharmacology December 1999, 56 (6) 1219-1228; DOI: https://doi.org/10.1124/mol.56.6.1219
  • You have access
    Pivotal Role for the Cytoplasmic Carboxyl-Terminal Tail of a Nonmammalian Gonadotropin-Releasing Hormone Receptor in Cell Surface Expression, Ligand Binding, and Receptor Phosphorylation and Internalization
    Marion Blomenröhr, Anders Heding, Robin Sellar, Rob Leurs, Jan Bogerd, Karin A. Eidne and Gary B. Willars
    Molecular Pharmacology December 1999, 56 (6) 1229-1237; DOI: https://doi.org/10.1124/mol.56.6.1229
  • You have access
    Differential Interaction of R-Mexiletine with the Local Anesthetic Receptor Site on Brain and Heart Sodium Channel α-Subunits
    Thomas Weiser, Yusheng Qu, William A. Catterall and Todd Scheuer
    Molecular Pharmacology December 1999, 56 (6) 1238-1244; DOI: https://doi.org/10.1124/mol.56.6.1238
  • You have access
    Site-Directed Mutagenesis Reveals Two Epitopes Involved in the Subtype Selectivity of the Allosteric Interactions of Gallamine at Muscarinic Acetylcholine Receptors
    Ann L. Gnagey, Margaret Seidenberg and John Ellis
    Molecular Pharmacology December 1999, 56 (6) 1245-1253; DOI: https://doi.org/10.1124/mol.56.6.1245
  • You have access
    Selectivity of the Polyspecific Cation Transporter rOCT1 Is Changed by Mutation of Aspartate 475 to Glutamate
    Valentin Gorboulev, Christopher Volk, Petra Arndt, Aida Akhoundova and Hermann Koepsell
    Molecular Pharmacology December 1999, 56 (6) 1254-1261; DOI: https://doi.org/10.1124/mol.56.6.1254
  • You have access
    9-(2-Phosphonylmethoxyethyl) Derivatives of Purine Nucleotide Analogs: A Comparison of Their Metabolism and Interaction with Cellular DNA Synthesis
    Pavel Kramata and Kathleen M. Downey
    Molecular Pharmacology December 1999, 56 (6) 1262-1270; DOI: https://doi.org/10.1124/mol.56.6.1262
  • You have access
    c-Jun N-Terminal Kinase Mediates Apoptotic Signaling Induced byN-(4-Hydroxyphenyl)retinamide
    Yi-Rong Chen, Guisheng Zhou and Tse-Hua Tan
    Molecular Pharmacology December 1999, 56 (6) 1271-1279; DOI: https://doi.org/10.1124/mol.56.6.1271
  • You have access
    Different Vasoactive Intestinal Polypeptide Receptor Domains Are Involved in the Selective Recognition of Two VPAC2-Selective Ligands
    Maria G. Juarranz, Jean Van Rampelbergh, Philippe Gourlet, Philippe De Neef, Johnny Cnudde, Patrick Robberecht and Magali Waelbroeck
    Molecular Pharmacology December 1999, 56 (6) 1280-1287; DOI: https://doi.org/10.1124/mol.56.6.1280
  • You have access
    Cloning, Cell-Type Specificity, and Regulatory Function of the Mouse α1B-Adrenergic Receptor Promoter
    Michael J. Zuscik, Michael T. Piascik and Dianne M. Perez
    Molecular Pharmacology December 1999, 56 (6) 1288-1297; DOI: https://doi.org/10.1124/mol.56.6.1288
  • You have access
    Modulation of the K+ Channels Encoded by the Human Ether-a-Gogo-Related Gene-1 (hERG1) by Nitric Oxide
    Maurizio Taglialatela, Anna Pannaccione, Silvana Iossa, Pasqualina Castaldo and Lucio Annunziato
    Molecular Pharmacology December 1999, 56 (6) 1298-1308; DOI: https://doi.org/10.1124/mol.56.6.1298
  • You have access
    Murine Transgenic Cells Lacking DNA Topoisomerase IIβ Are Resistant to Acridines and Mitoxantrone: Analysis of Cytotoxicity and Cleavable Complex Formation
    F. Errington, E. Willmore, M. J. Tilby, L. Li, G. Li, W. Li, B. C. Baguley and C. A. Austin
    Molecular Pharmacology December 1999, 56 (6) 1309-1316; DOI: https://doi.org/10.1124/mol.56.6.1309
  • You have access
    Bone Marrow Stromal Cell Cytochrome P4501B1 Is Required for Pre-B Cell Apoptosis Induced by 7,12-Dimethylbenz[a]anthracene
    Shawn M. Heidel, Karrie Holston, Jeroen T.M. Buters, Frank J. Gonzalez, Colin R. Jefcoate and Charles J. Czupyrynski
    Molecular Pharmacology December 1999, 56 (6) 1317-1323; DOI: https://doi.org/10.1124/mol.56.6.1317
  • You have access
    Protective Effects of Triterpene Compounds Against the Cytotoxicity of Cadmium in HepG2 Cells
    Nobuhiko Miura, Yoko Matsumoto, Shinichi Miyairi, Shoji Nishiyama and Akira Naganuma
    Molecular Pharmacology December 1999, 56 (6) 1324-1328; DOI: https://doi.org/10.1124/mol.56.6.1324
  • You have access
    The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
    Bryan Goodwin, Ecushla Hodgson and Christopher Liddle
    Molecular Pharmacology December 1999, 56 (6) 1329-1339; DOI: https://doi.org/10.1124/mol.56.6.1329
  • You have access
    Altered Drug Interaction and Regulation of Topoisomerase IIβ: Potential Mechanisms Governing Sensitivity of HL-60 Cells to Amsacrine and Etoposide
    Dale R. Grabowski, Katherine A. Holmes, Masako Aoyama, Ying Ye, Lisa A. Rybicki, Ronald M. Bukowski, Mahrukh K. Ganapathi, Ian D. Hickson and Ram Ganapathi
    Molecular Pharmacology December 1999, 56 (6) 1340-1345; DOI: https://doi.org/10.1124/mol.56.6.1340
  • You have access
    The Mechanism for the Inhibition of Acetylcholinesterases by Irinotecan (CPT-11)
    Helen M. Dodds and Laurent P. Rivory
    Molecular Pharmacology December 1999, 56 (6) 1346-1353; DOI: https://doi.org/10.1124/mol.56.6.1346
  • You have access
    Intracellular Metabolism of CycloSaligenyl 3′-Azido-2′,3′-dideoxythymidine Monophosphate, a Prodrug of 3′-Azido-2′,3′-dideoxythymidine (Zidovudine)
    Jan Balzarini, Lieve Naesens, S. Aquaro, T. Knispel, C.-F. Perno, E. De Clercq and C. Meier
    Molecular Pharmacology December 1999, 56 (6) 1354-1361; DOI: https://doi.org/10.1124/mol.56.6.1354
  • You have access
    Agonist Selective Regulation of G Proteins by Cannabinoid CB1 and CB2 Receptors
    Michelle Glass and John K. Northup
    Molecular Pharmacology December 1999, 56 (6) 1362-1369; DOI: https://doi.org/10.1124/mol.56.6.1362

Accelerated Communication

  • You have access
    Stoichiometry of Potassium Channel Opener Action
    Insa Gross, Andreas Toman, Ingo Uhde, Christina Schwanstecher and Mathias Schwanstecher
    Molecular Pharmacology December 1999, 56 (6) 1370-1373; DOI: https://doi.org/10.1124/mol.56.6.1370

Erratum

  • You have access
    Molecular Pharmacology December 1999, 56 (6) 1374; DOI: https://doi.org/10.1124/mol.56.6.1374
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 56 (6)
Molecular Pharmacology
Vol. 56, Issue 6
1 Dec 1999
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Articles
  • Accelerated Communication
  • Erratum
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics